AlphAIalphai — Financial news for AI agents
baystreet.caAUG 71 min read$LFWD

Lifeward Out With Q2 Numbers

Lifeward Ltd. (NASDAQ: LFWD) said it will release its Q2 2026 financial results on Friday, Aug. 14, via a press release and an SEC quarterly report filed before 9:30 a.m. ET. The company highlighted its neurorehabilitation products and its Protein Oral Delivery platform, including ORMD-0801 oral insulin.

Original reporting
baystreet.ca
Published Aug 7, 2026, 6:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 6:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Lifeward Out With Q2 Numbers — source image
Source · baystreet.ca
Decision brief

The 30-second read

$LFWDNeutralMed
01

Why it matters

This primarily affects short-term trading around the earnings window; the article does not disclose any new Q2 performance metrics or forward-looking guidance.

02

Market read

A scheduled earnings date can be used to plan options/volatility exposure, but the text provides no new numbers to reprice fundamentals yet.

03

What to watch

Volatility may be driven more by expectations and positioning than by the mere announcement of the reporting date.

Relevance 5/10Novelty 3/10Timing: ahead of Aug. 14 pre-market Q2 earnings release

Background

The company states it will report Q2 2026 financial results on Friday, Aug. 14, with a press release and SEC filing before 9:30 a.m. ET.

Company-level read

Ticker impact

$LFWDNeutralMedium confidence
Context

Lifeward (LFWD) announced it will report Q2 2026 results on Aug. 14 before 9:30 a.m. ET, setting a near-term catalyst.

Expected impact

Likely modest pre-earnings drift and higher implied volatility into the Aug. 14 release; direction depends on the forthcoming Q2 print and guidance.

Evidence & confidence

No Q2 numbers, guidance, or new operational developments are provided, only the reporting date and SEC/press-release timing.

Market effects

Sector

Adds a single-name earnings catalyst in biomedical/rehab robotics, but provides no sector-wide signal.

Regional

No specific regional macro or regulatory linkage mentioned.

Global

Mentions global commercialization and pipeline, but no new international event or data.

Counterpoint

What could challenge this read

Because the article contains no new financials or guidance, traders may treat it as routine and focus only on the actual Aug. 14 release.

Key entities

  • public_company
    Lifeward Ltd.

    NASDAQ-listed biomedical innovation company scheduled to report Q2 2026 results on Aug. 14 before 9:30 a.m. ET.

  • product_candidate
    ORMD-0801

    Lead candidate in the Protein Oral Delivery (POD) platform, described as oral insulin targeting diabetes.

Read at source← All news

Related articles

JUL 7
$LFWDMedAI 8/10

Lifeward stock rises on $5.6M funding with milestone upside By Investing.com

Lifeward Ltd. (NASDAQ:LFWD) shares rose 5.6% after hours after the company said it raised $5.6M via senior secured convertible notes and warrants, with another $5.6M available upon milestones: a 150% increase in ReWalk unit sales or shares trading at/above $13.80 for 10 straight days. Lifeward links the financing to a strategic framework with Oramed (NASDAQ:ORMP).

investing.com3 min
AUG 10
$BHVNMed

Biohaven Ltd. (BHVN): Results of Operations and Financial Condition

Biohaven Ltd. (BHVN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026q2bhvnearningsprex991.htm EX-99.1 Document Exhibit 99.1 Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results • First extracellular protein degraders in the clinic demonstrate rapid and robust pharmacodynamic effects and compelling

SEC EDGAR 8-K6 min
AUG 10
$RIOTHighAI 9/10

Riot Platforms, Inc. (RIOT): Results of Operations and Financial Condition

Riot Platforms, Inc. (RIOT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 riot-20260810xex99d1.htm EX-99.1 Exhibit 99.1 Riot Platforms Reports Second Quarter 2026 Financial Results and Strategic Highlights Executed 20-year data center lease with a leading frontier AI lab for 191 MW of critical IT capacity at Riot’s Rockdale campus, expected t

SEC EDGAR 8-K6 min
AUG 10
$GDOTMed

GREEN DOT CORP (GDOT): Results of Operations and Financial Condition

GREEN DOT CORP (GDOT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.01 2 a06302026-exb9901earningsr.htm EX-99.01 Document Exhibit 99.01 Green Dot Reports Second Quarter 2026 Results Company Delivers Another Quarter of Solid Performance as It Makes Progress Modernizing Its Platform and Optimizing Its Balance Sheet in Preparation for Acquisit

SEC EDGAR 8-K6 min
AUG 10
$KLXEMed

KLX Energy Services Holdings, Inc. (KLXE): Results of Operations and Financial Condition

KLX Energy Services Holdings, Inc. (KLXE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 klxeq22026earningsreleasee.htm EX-99.1 Document NEWS RELEASE Contacts: KLX Energy Services Holdings, Inc. Geoffrey C. Stanford, SVP, Interim CFO & CAO 832-930-8066 IR@klx.com Dennard Lascar Investor Relations Ken Dennard / Natalie Hairston 713-529-6600 KLXE@dennardlasca

SEC EDGAR 8-K6 min